← Leaderboards
John Anthony Muraski
Endurx Pharmaceuticals, Inc.
$637,111
Attributed
$1,274,221
Total exposure
1
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $1.1M · FY2014–15$2M$1.5M$1M$500K$0
'14
'15
Funding mix
By agency
NIH$1,274,221 · 1
By mechanism
R44$1,274,221 · 1
Top collaborators
- Erkki I Ruoslahti2 shared
Most similar at Endurx Pharmaceuticals, Inc.
Same institution · by research overlap
- David Bramhill$217,745
Others in their field
Top investigators on “Apoptotic”
- Douglas R Green · Burnham Institute For Medical Research$36,561,515
- Ira A Tabas · Columbia University Health Sciences$25,367,980
- Robert L Ferris · University Of Pittsburgh At Pittsburgh$21,268,306
- Anthony G Letai · Dana-Farber Cancer Inst$20,781,967
- Augustine M Choi · Weill Medical Coll Of Cornell Univ$19,019,183
- Loren D Walensky · Northeastern University$17,252,485
Research focus
ApoptoticBinding (Molecular Function)BiologicalBrain TissueCancer DiagnosisCancer TherapyCanis FamiliarisCellsCell SurfaceChemotherapyContrast MediaCoupledCouplingCutaneousDesignDiagnostic ImagingDoseDrug FormulationsDrug KineticsDrug ResistanceEffective TherapyGlioblastomaHandAnalog